2015PubMedOpen access

Progress in histopathologic and pathogenetic research in a retinitis pigmentosa model.

Xin Liu, Yan Zhang, Yuxi He, Jinsong Zhao, Guanfang Su

Open full text 15 citations

Abstract

Retinitis pigmentosa is a major cause of visual impairment and blindness, affecting millions of people worldwide. The mechanisms of and effective treatments for the disease, however, remain to be further investigated. The Royal College of Surgeons rat is one of the most widely used animal models for the study of retinal degeneration diseases. The mutation in the mer tyrosine kinase proto-oncogene of this model leads to deficient phagocytosis in the retinal pigment epithelium cells and the accumulation of photoreceptor out segments in the subretinal space, ultimately resulting in retinal degeneration. The retina begins to change as early as 17 days after birth and becomes gradually thinner with the death and remodeling of cells and blood vessels. Retinal cell apoptosis plays a dominant role in this degeneration, with some cells being activated by the secondary alterations of the retinal neurotransmitter and other related factors.

About this research paper

What this paper is about

Retinitis pigmentosa is a major cause of visual impairment and blindness, affecting millions of people worldwide. The mechanisms of and effective treatments for the disease, however, remain to be further investigated. The Royal College of Surgeons rat is one of the most widely used animal models for the study of retinal degeneration diseases. The mutation in the mer tyrosine kinase proto-oncogene of this model leads to deficient phagocytosis in the retinal pigment epithelium cells and the accumulation of photoreceptor out segments in the subretinal space, ultimately resulting in retinal degeneration. The retina begins to change as early as 17 days after birth and becomes gradually thinner with the death and remodeling of cells and blood vessels. Retinal cell apoptosis plays a dominant role in this degeneration, with some cells being activated by the secondary alterations of the retinal neurotransmitter and other related factors.

Why it matters

OpenAlex reports 15 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Retinitis pigmentosa is a major cause of visual impairment and blindness, affecting millions of people worldwide. The mechanisms of and effective treatments for the disease, however, remain to be further investigated. The Royal College of Surgeons rat is one of the most widely used animal models for the study of retinal degeneration diseases. The mutation in the mer tyrosine kinase proto-oncogene of this model leads to deficient phagocytosis in the retinal pigment epithelium cells and the accumulation of photoreceptor out segments in the subretinal space, ultimately resulting in retinal degeneration. The retina begins to change as early as 17 days after birth and becomes gradually thinner with the death and remodeling of cells and blood vessels. Retinal cell apoptosis plays a dominant role in this degeneration, with some cells being activated by the secondary alterations of the retinal neurotransmitter and other related factors.

Key concepts: Retinitis pigmentosa, Retinal degeneration, Photoreceptor cell, Gene therapy of the human retina, Retina, Degeneration (medical), Retinal pigment epithelium, Retinal

Related papers

Back to paper searchBrowse research topicsOriginal source
Progress in histopathologic and pathogenetic research in a retinitis pigmentosa model. — Research Paper | ScholarLens